Shady Kamal

Shady Kamal, PhD, is Principal Scientist, Manufacturing Science & Technology, at Galderma, Uppsala, Sweden, and Affiliate Researcher at Karolinska Institutet, Stockholm.

He specializes in microbiological method development and validation, contamination control, and bacterial endotoxin testing, applying science-driven approaches to the manufacture of injectable biopharmaceuticals. He serves as an Expert Committee Member on the EDQM Bacterial Endotoxin Testing Working Party, contributing to the development and revision of European Pharmacopoeia standards, and is involved in the PDA Technical Report 82 revision. His career includes research appointments at MIT, Heidelberg University, and the University of Basel, with publications on microbial resistance and stress adaptation, bridging academic rigor and industry practice.